Table 5.
Surgery data and outcomes.
| AUTHOR/YEAR | Ankle arthritis etiology | Implant | Outcomes MEASURE | Significance pre & post-op | Outcome pre-op | Outcome post-op |
|---|---|---|---|---|---|---|
| B. FRAM ET AL. -202238 | Primary OA, PTA, AA or TAA revision with bone stock | Semiconstrained prosthesis Cadence (Integra LifeScience, Plainsboro,NJ) | FAAM, VAS, SF-12 score | FAAM (p < .001) VAS (p < .001) SF-12 (NS) |
FAAM sport: 23.7 (18.2) | FAAM sport: 53.5 (32.5) |
| B. CHO ET AL - 202113 | OA (45), RA (19) | 3-component mobile-bearing prosthesis Zenith (Corin, Cirencester, UK) | AOFAS, FAOS, FAAM score | AOFAS (p < .001) FAOS (p < .001) FAAM (p < .001) |
FAAM sport: 26.7 (7.5) [OA] 28.9 (8.1) [RA] |
FAAM sport: 62.5 (13.6) [OA] 56.4 (13.2) [RA] |
| B.J. SANGEORZAN ET AL - 202127 | PTA (213), OA (71), Instability (103), other (26) | 211 (51.0%) Salto Talaris Ankle (Integra LifeSciences); 174 (42.0%) INBONE Total Ankle System (Wright Medical); 23 (5.6%) STAA (Stryker); 5 (1.2%) Trabecular Metal Total Ankle (Zimmer Biomet) and 1 other. | FAAM, SF-36, CPG score | FAAM (p < .001) SF-36 physical (p < .001) SF-36 mental (NS) CPG (p < .001) |
FAAM sport: 19.8 (2.0) | FAAM sport: 37.4 (1.4) |
| B.A. HENDY ET AL -201836 | PTA (53), OA (47), RA (9) | Fixed-bearing prosthesis Salto Talaris ankle implant (Integra LifeSciences) | VAS, FAAM, SF-12 score | VAS (p < .001) FAAM (p < .001) SF-12 (p < .001) |
FAAM sport: 18.8 | FAAM sport: 50.0 |
| S.M. RAIKIN ET AL -201714 | PTA (72), OA (36), RA (7) | Semiconstrained prosthesis Agility (DePuy, Warsaw, IN) | VAS, FAAM, SF-12 score | / | / | FAAM sport: 55.3 |
| F.G. USUELLI ET AL - 20178 | PTA (70), RA (3), other (3) | 3-component mobile-bearing Hintegra (Newdeal SA, Lyon, France) | UCLA, SF-12, AOFAS, VAS, sports participation | UCLA (P < .001) SF-12 (p < .001) AOFAS (p < .001) VAS (p < .001) |
UCLA: 2.4 (0.8) | UCLA: 6.3 (2.3) |
| F. DALAT ET AL - 201415 | OA (29), RA (3) | 3-component mobile-bearing AES Biomet (BiometInc., Valence, France) | AOFAS, FAAM, FFI, SF-36, sports participation | / | / | FAAM sport: 49.5 (24.4) |
| R. SCHUH ET AL - 20129 | OA | 3-component mobile-bearing Hintegra (Newdeal SA, Lyon, France) | UCLA, AOFAS, sports participation, Ankle Activity score | Ankle Activity score (p < .05) worsening | Ankle activity score: 4.7 (2.3) |
Ankle activity score: 3.3 (2.7) UCLA: 6.8 (1.8) |
| F.D. NAAL ET AL - 200910 | Primary OA (35), PTA (47), RA (19) | 3-component uncemented Buechel-Pappas implant (Endotec Inc, South Orange, New Jersey) in 47, 3-component uncemented Mobility prosthesis DePuy Orthopaedics (Warsaw, Indiana) in 54 |
UCLA, AOFAS, IPAQ | UCLA (P < .001) AOFAS (p < .001) |
UCLA: 4.3 (2.2) | UCLA: 6.2 (1.6) |
| M.P. BONNIN ET AL - 200912 | Primary OA (30), PTA (70), RA (40) | Mobile-bearing cementeless Salto total ankle prostheses (Tornier SA, Montbonnot, France) |
AOFAS, FFI, FAAM, VAS, sports participation | / | / | FAAM sport: 48.9 (28) VAS sport [0–100] (100 was level before ankle patology: 53.7 (28) |
| V. VALDERRABANO ET AL - 200611 | Primary OA (21), PTA (115), RA (16) | 3-component mobile-bearing Hintegra (Newdeal SA, Lyon, France) | VAS, AOFAS, ROM, sports participation | VAS (p < .001) AOFAS (p < .001) ROM (p = .04) |
/ | / |
Abbreviations:PTA post traumatic arthritis; RA rheumatoid arthritis; OA osteoarthritis; AA Ankle Artrodesis; FAAM Foot and Ankle Ability Measure; AOFAS American Orthopaedic Foot & Ankle Society; FAOS Foot and Ankle Outcome Score; AOS Ankle Osteoarthritis Scale; SF-# Short Form - #; FFI Foot Function Index; CPG Chronic Pain Grade; VR-12Veterans RAND 12 Item Health Survey; UCLA University of California at Los Angeles; FADI Foot & Ankle Disability Index; SMFA Short Musculoskeletal Function Assessment; SPPB Short Physical Performance Battery; FSST Four-Square Step Test; ROM Range of motion; IPAQ International Physical Activity Questionnaire.